https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Interparticle repulsion of microparticles delivered to a pendent drop by an electric field https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40950 Wed 20 Jul 2022 13:51:23 AEST ]]> The origin of circulating CD36 in type 2 diabetes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20054 c. By contrast, the main source of CD36+MPs in non-T2DM individuals was endothelial cells (CD105+=40.9±8.3% and 33.9±8.3% for lean and obese controls, respectively). Across the entire cohort, plasma CD36 protein concentration varied from undetectable to 22.9 μg ml⁻¹ and was positively correlated with CD36+MPs measured by flow cytometry (P=0.0006) but only weakly associated with the distribution of controls and T2DM (P=0.021). Multivariate analysis confirmed that plasma CD36+MP levels were a much better biomarker for diabetes than CD36 protein concentration (P=0.009 vs P=0.398, respectively). Conclusions: Both the levels and cellular profile of CD36+MPs differ in T2DM compared with controls, suggesting that these specific vesicles could represent distinct biological vectors contributing to the pathology of the disease.]]> Wed 11 Apr 2018 16:13:53 AEST ]]> The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9178 Wed 11 Apr 2018 15:35:19 AEST ]]> Biogenesis of plasma CD36+microparticles in human diabetes and the metabolic syndrome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12420 Wed 11 Apr 2018 11:53:47 AEST ]]> Bio-maleimide-stained plasma microparticles can be purified in a native state and target human proximal tubular HK₂ cells https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34397 in vitro. Notably, only the first eluted MP fraction bound HK₂ cells indicating a possible association between MP size and cell‑targeting properties.]]> Tue 03 Sep 2019 18:26:10 AEST ]]> Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53405 Thu 23 Nov 2023 13:43:18 AEDT ]]> Bio-maleimide as a generic stain for detection and quantitation of microparticles https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5365 Thu 21 Feb 2019 08:32:59 AEDT ]]> Circulating microparticles are elevated in carriers of Factor V Leiden https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9688 Sat 24 Mar 2018 08:39:15 AEDT ]]> Microparticles in health and disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5366 Sat 24 Mar 2018 07:43:59 AEDT ]]> Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25886 Sat 24 Mar 2018 07:25:52 AEDT ]]> Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22547 Sat 24 Mar 2018 07:14:44 AEDT ]]> Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG₂ cells: an in vitro model of non-alcoholic fatty liver disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24678 in vivo and to determine the underlying mechanism by which simvastatin reduces hepatic steatosis.]]> Sat 24 Mar 2018 07:10:52 AEDT ]]> Investigating the role of microparticles/ microvesicles/extracellular vesicles in vascular biology, haemostasis and haemopoietic dysregulation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34877 Mon 23 Sep 2019 12:38:08 AEST ]]> Therapeutic prospects of microRNAs in cancer treatment through nanotechnology https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32345 Fri 01 Apr 2022 09:21:37 AEDT ]]>